Incidence and Risk Factors of Remnant Gastric Cancer after Gastrectomy for Gastric Cancer: A Population-Based Study from the SEER Database (2000-2020)

Author:

Yan Shangcheng1,Cheng Ming1,Peng Wei1,Liu Tianhua1,Zhang Jingyu1,Sheng Mengchao1,Ren Rui1,Chen Qiang1,Gong Wei1,Xing Chungen1,Wu Yongyou1

Affiliation:

1. Second Affiliated Hospital of Soochow University

Abstract

Abstract Background. Gastric cancer (GC) constitutes a major health problem in the U.S., of which remnant gastric cancer (RGC) occurs less frequently. The rate of RGCs after gastrectomy for GC is increasing recently due to improved survival and screening, however, their incidence and risk have not been reported in the U.S. population. The objective of this study was to evaluate the incidence and elevated risk of RGC after GC gastrectomy in the U.S., and to identify the risk factors. Methods. Patients diagnosed with first primary GC in 2000–2015 and those who developed RGC were identified from Surveillance, Epidemiology and End Results (SEER) database. Fine-Gray regression was used to estimate the cumulative incidence and to identify risk factors. Standardized incidence ratios (SIRs) were calculated by Poisson regression to compare the risk with the general population. Results. Among 21566 patients included in the cohort, 227 developed RGC. The 20-year cumulative incidence of RGC was 1.88%. Multivariate analysis showed that hazard ratios were significantly higher in patients with age over 55 years, widowed and single marital status, unspecified tumor site, and T4 tumor, but lower in patients with diagnosis in 2010–2015, female sex, and $75000 + income. SIR was 7.70 overall and > 4.5 in each stratum. Conclusions. Cumulative incidence and risk for RGCs increased continuously in patients underwent GC gastrectomy. Earlier diagnosis, older age, male sex, marital status, lower income, and invasion depth are independent risk factors for RGC development. Close and lifelong endoscopy surveillance should be recommended for these patients.

Publisher

Research Square Platform LLC

Reference34 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA: a cancer journal for clinicians,2021

2. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Ajani JA;J Natl Compr Canc Netw,2022

3. Prevalence and characteristics of gastric remnant cancer: A systematic review and meta-analysis;Mak TK;Asian J Surg,2021

4. Balfour DC. FACTORS INFLUENCING THE LIFE EXPECTANCY OF PATIENTS OPERATED ON FOR GASTRIC ULCER. Ann Surg. 1922;76(3):405–8.

5. Appraisal of gastric stump carcinoma and current state of affairs;Shukla A;World J Clin Cases,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3